These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36214454)

  • 21. Cloning and characterization of human phosphomannomutase, a mammalian homologue of yeast SEC53.
    Hansen SH; Frank SR; Casanova JE
    Glycobiology; 1997 Sep; 7(6):829-34. PubMed ID: 9376685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural and metabolic dysregulation in PMM2-deficient human in vitro neural models.
    Radenkovic S; Budhraja R; Klein-Gunnewiek T; King AT; Bhatia TN; Ligezka AN; Driesen K; Shah R; Ghesquière B; Pandey A; Kasri NN; Sloan SA; Morava E; Kozicz T
    Cell Rep; 2024 Mar; 43(3):113883. PubMed ID: 38430517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain.
    Medrano C; Vega A; Navarrete R; Ecay MJ; Calvo R; Pascual SI; Ruiz-Pons M; Toledo L; García-Jiménez I; Arroyo I; Campo A; Couce ML; Domingo-Jiménez MR; García-Silva MT; González-Gutiérrez-Solana L; Hierro L; Martín-Hernández E; Martínez-Pardo M; Roldán S; Tomás M; Cabrera JC; Mártinez-Bugallo F; Martín-Viota L; Vitoria-Miñana I; Lefeber DJ; Girós ML; Serrano Gimare M; Ugarte M; Pérez B; Pérez-Cerdá C
    Clin Genet; 2019 May; 95(5):615-626. PubMed ID: 30653653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphoglucomutase-1 deficiency: Early presentation, metabolic management and detection in neonatal blood spots.
    Conte F; Morava E; Bakar NA; Wortmann SB; Poerink AJ; Grunewald S; Crushell E; Al-Gazali L; de Vries MC; Mørkrid L; Hertecant J; Brocke Holmefjord KS; Kronn D; Feigenbaum A; Fingerhut R; Wong SY; van Scherpenzeel M; Voermans NC; Lefeber DJ
    Mol Genet Metab; 2020; 131(1-2):135-146. PubMed ID: 33342467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Cell Models to Study Monocyte Functions in PMM2 Congenital Disorders of Glycosylation.
    de Haas P; de Jonge MI; Koenen HJPM; Joosten B; Janssen MCH; de Boer L; Hendriks WJAJ; Lefeber DJ; Cambi A
    Front Immunol; 2022; 13():869031. PubMed ID: 35603178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissecting the transcriptional program of phosphomannomutase 2-deficient cells: Lymphoblastoide B cell lines as a valuable model for congenital disorders of glycosylation studies.
    Parrado A; Rubio G; Serrano M; De la Morena-Barrio ME; Ibáñez-Micó S; Ruiz-Lafuente N; Schwartz-Albiez R; Esteve-Solé A; Alsina L; Corral J; Hernández-Caselles T
    Glycobiology; 2022 Mar; 32(2):84-100. PubMed ID: 34420056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG.
    Iyer S; Sam FS; DiPrimio N; Preston G; Verheijen J; Murthy K; Parton Z; Tsang H; Lao J; Morava E; Perlstein EO
    Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31636082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KlSEC53 is an essential Kluyveromyces lactis gene and is homologous with the SEC53 gene of Saccharomyces cerevisiae.
    Staneva D; Uccelletti D; Farina F; Venkov P; Palleschi C
    Yeast; 2004 Jan; 21(1):41-51. PubMed ID: 14745781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression analysis revealing destabilizing mutations in phosphomannomutase 2 deficiency (PMM2-CDG): expression analysis of PMM2-CDG mutations.
    Vega AI; Pérez-Cerdá C; Abia D; Gámez A; Briones P; Artuch R; Desviat LR; Ugarte M; Pérez B
    J Inherit Metab Dis; 2011 Aug; 34(4):929-39. PubMed ID: 21541725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in the diagnosis and treatment of phosphomannomutase 2 deficiency].
    Zhou SY
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Feb; 25(2):223-228. PubMed ID: 36854702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New and potential strategies for the treatment of PMM2-CDG.
    Gámez A; Serrano M; Gallego D; Vilas A; Pérez B
    Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129686. PubMed ID: 32712172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypolipidaemia among patients with PMM2-CDG is associated with low circulating PCSK9 levels: a case report followed by observational and experimental studies.
    Chong M; Yoon G; Susan-Resiga D; Chamberland A; Cheillan D; Paré G; Seidah NG
    J Med Genet; 2020 Jan; 57(1):11-17. PubMed ID: 31391289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional analysis of novel mutations in a congenital disorder of glycosylation Ia patient with mixed Asian ancestry.
    Westphal V; Enns GM; McCracken MF; Freeze HH
    Mol Genet Metab; 2001 May; 73(1):71-6. PubMed ID: 11350185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency.
    Cline A; Gao N; Flanagan-Steet H; Sharma V; Rosa S; Sonon R; Azadi P; Sadler KC; Freeze HH; Lehrman MA; Steet R
    Mol Biol Cell; 2012 Nov; 23(21):4175-87. PubMed ID: 22956764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Population-Based Study on Congenital Disorders of Protein N- and Combined with O-Glycosylation Experience in Clinical and Genetic Diagnosis.
    Pérez-Cerdá C; Girós ML; Serrano M; Ecay MJ; Gort L; Pérez Dueñas B; Medrano C; García-Alix A; Artuch R; Briones P; Pérez B
    J Pediatr; 2017 Apr; 183():170-177.e1. PubMed ID: 28139241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal involvement in PMM2-CDG, a mini-review.
    Altassan R; Witters P; Saifudeen Z; Quelhas D; Jaeken J; Levtchenko E; Cassiman D; Morava E
    Mol Genet Metab; 2018 Mar; 123(3):292-296. PubMed ID: 29229467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital Disorders of Glycosylation in Portugal-Two Decades of Experience.
    Quelhas D; Martins E; Azevedo L; Bandeira A; Diogo L; Garcia P; Sequeira S; Ferreira AC; Teles EL; Rodrigues E; Fortuna AM; Mendonça C; Fernandes HC; Medeira A; Gaspar A; Janeiro P; Oliveira A; Laranjeira F; Ribeiro I; Souche E; Race V; Keldermans L; Matthijs G; Jaeken J
    J Pediatr; 2021 Apr; 231():148-156. PubMed ID: 33340551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13.
    Matthijs G; Schollen E; Pirard M; Budarf ML; Van Schaftingen E; Cassiman JJ
    Genomics; 1997 Feb; 40(1):41-7. PubMed ID: 9070917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic modifiers in glycosylation pathways: Is there a link between PMM2 and PGM1?
    Quelhas D; Jaeken J; Azevedo L
    J Inherit Metab Dis; 2023 Jan; 46(1):1-2. PubMed ID: 36451346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.